Literature DB >> 9617352

Antitumor effect sonodynamically induced by focused ultrasound in combination with Ga-porphyrin complex.

K Sasaki1, N Yumita, R Nishigaki, S Umemura.   

Abstract

The antitumor effect of focused ultrasound in combination with Ga-porphyrin complex, 7,12-bis(1-decyloxyethyl)-Ga(III)-3,8,13,17 tetramethylporphyrin-2,18-dipropionyl diaspartic acid (ATX-70), on the growth of experimental murine tumors was examined. Walker 256 tumors implanted in rat kidneys were exposed in a progressive wave field for 5 min to focused ultrasound at 500 kHz with the second harmonic (at 1 MHz) superimposed after administration of ATX-70 to the rats. A significant antitumor effect was obtained at a focal-spot average acoustic intensity of 12 W/cm2 or higher with an ATX-70 dose of not less than 2.5 mg/kg. When the acoustic intensity was 8 W/cm2 or lower, no significant effect was observed even at an ATX-70 dose of 2.5 mg/kg. Also when the ATX-70 dose was 1.0 mg/kg or lower, no significant effect was observed even at a focal-spot average acoustic intensity of 40 W/cm2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9617352      PMCID: PMC5921827          DOI: 10.1111/j.1349-7006.1998.tb00584.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  11 in total

1.  In vitro and in vivo enhancement of sonodynamically active cavitation by second-harmonic superimposition.

Authors:  S Umemura; K Kawabata; K Sasaki
Journal:  J Acoust Soc Am       Date:  1997-01       Impact factor: 1.840

2.  Porphyrin-lipoprotein association as a factor in porphyrin localization.

Authors:  D Kessel
Journal:  Cancer Lett       Date:  1986-11       Impact factor: 8.679

3.  Sonodynamically induced antitumor effect of gallium-porphyrin complex by focused ultrasound on experimental kidney tumor.

Authors:  N Yumita; K Sasaki; S Umemura; A Yukawa; R Nishigaki
Journal:  Cancer Lett       Date:  1997-01-15       Impact factor: 8.679

4.  Sonochemical activation of hematoporphyrin: an ESR study.

Authors:  N Yumita; R Nishigaki; K Umemura; P D Morse; H M Swartz; C A Cain; S Umemura
Journal:  Radiat Res       Date:  1994-05       Impact factor: 2.841

5.  Distribution and elimination of Photofrin II in mice.

Authors:  D A Bellnier; Y K Ho; R K Pandey; J R Missert; T J Dougherty
Journal:  Photochem Photobiol       Date:  1989-08       Impact factor: 3.421

6.  Subharmonic emission as an indicator of ultrasonically-induced biological damage.

Authors:  K I Morton; G R Ter Haar; I J Stratford; C R Hill
Journal:  Ultrasound Med Biol       Date:  1983 Nov-Dec       Impact factor: 2.998

7.  Synergistic effect of ultrasound and hematoporphyrin on sarcoma 180.

Authors:  N Yumita; R Nishigaki; K Umemura; S Umemura
Journal:  Jpn J Cancer Res       Date:  1990-03

8.  Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound.

Authors:  N Yumita; R Nishigaki; K Umemura; S Umemura
Journal:  Jpn J Cancer Res       Date:  1989-03

9.  Sonodynamically induced antitumor effect of a gallium-porphyrin complex, ATX-70.

Authors:  N Yumita; K Sasaki; S Umemura; R Nishigaki
Journal:  Jpn J Cancer Res       Date:  1996-03

10.  Enhancement of ultrasonically induced cell damage by a gallium-porphyrin complex, ATX-70.

Authors:  S Umemura; N Yumita; R Nishigaki
Journal:  Jpn J Cancer Res       Date:  1993-05
View more
  3 in total

Review 1.  Sound waves and antineoplastic drugs: The possibility of an enhanced combined anticancer therapy.

Authors:  Loreto B Feril; Takashi Kondo; Shin-Ichiro Umemura; Katsuro Tachibana; Angelo H Manalo; Peter Riesz
Journal:  J Med Ultrason (2001)       Date:  2002-12       Impact factor: 1.314

2.  Study of the mechanism of sonodynamic therapy in a rat glioma model.

Authors:  Dayong Song; Wu Yue; Zhiqiang Li; Jianhua Li; Jun Zhao; Ning Zhang
Journal:  Onco Targets Ther       Date:  2014-09-30       Impact factor: 4.147

3.  Pharmacokinetic study of a gallium-porphyrin photo- and sono-sensitizer, ATX-70, in tumor-bearing mice.

Authors:  K Sasaki; N Yumita; R Nishigaki; I Sakata; S Nakajima; S I Umemura
Journal:  Jpn J Cancer Res       Date:  2001-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.